Full access

Letters to the Editor

Published Online: 1 September 2008

Dr. Wu Replies

REN-RONG WU, M.D.Authors Info & Affiliations

Publication: American Journal of Psychiatry

https://doi.org/10.1176/appi.ajp.2008.08030432r

To the Editor: We thank Drs. Alamiri and Balf for their comments. In response to Dr. Alamiri, olanzapine remained at a fixed dose in our study in order to attenuate the effect of different doses of the drug on body weight. Furthermore, in China it is standard practice to treat patients with acute episode psychosis with olanzapine in doses of 10–20 mg per day.

Regarding the reporting of adverse events, we would like to note that because there were such few events, we only reported emergent adverse events.

We would also like to clarify that the mean duration of illness should have been 6.8 months for the metformin group and 7.6 months for the placebo group, and we are glad to have the opportunity to make this correction.

Although we recognize that completer analysis and intent-to-treat analysis are methods that may contain some biases, we did not find a good approach to avoid these biases.

It is possible for metformin to reduce caloric intake. In our study, the total caloric intake range was 7,980–9,250 kilojoule per day, and we did not evaluate changes in caloric intake or control food intake because we examined these issues in a previous analysis (1) .

Metformin treatment can induce some severe adverse events, such as lactic acidosis, which remains a potential issue concerning its use. In future studies, it is necessary to conduct a risk-benefit assessment of metformin treatment, monitor for adverse events, and examine antipsychotic-metformin pharmacokinetic interactions.

Footnotes

The author’s disclosures accompany the original article.

This letter (doi: 10.1176/appi.ajp.2008.08030432r) was accepted for publication in May 2008.

Reference

Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, He YQ, Liu YJ, Chen JD, Li LH: Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008; 299:185–193

Google Scholar

Information & Authors

Information

Published In

American Journal of Psychiatry

Volume 165 • Number 9 • September, 2008

Pages: 1207

History

Published online: 1 September 2008

Published in print: September, 2008

Authors

Affiliations

REN-RONG WU, M.D.

Hunan, China

View all articles by this author

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format	RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks
Direct importt
Citation style
Style

Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR^® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Dr. Wu Replies

Footnotes

Reference